ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,507Medicare Part D Prescriptions Filled, Including Refills

Rank: 746 out of 6645

$3.95M Total Retail Price of All Prescriptions

Rank: 12 out of 6645

243 Patients Receiving at Least One Drug in Part D
38%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 243 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

30% of this provider’s 243 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

0% of this provider’s 1,988 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$376 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ISENTRESS 480 61 1 173
NORVIR 343 15 2 133
TRUVADA 340 61 3 135
ACYCLOVIR 306 26 4 206
EPZICOM 272 65 5 223
VIRAMUNE XR 238 69 10 6 371
VIREAD 216 17 7 259
PREZISTA 216 0 7 194
ATORVASTATIN CALCIUM 190 96 9 10
HYDROCODONE-ACETAMINOPHEN 189 33 S3 10 5
INTELENCE 181 14 11 305
BUPROPION XL 174 20 12 225
TESTOSTERONE CYPIONATE 157 0 S3 13 324
CYMBALTA 156 20 14 78
SELZENTRY 156 12 10 14 428
GABAPENTIN 155 14 16 18
OMEPRAZOLE 154 31 17 6
REYATAZ 147 17 18 197
VALACYCLOVIR 146 28 19 271
METHYLPHENIDATE HCL 144 0 20 588
ZOLPIDEM TARTRATE 131 35 21 17
OXYCONTIN 130 32 S2 22 236
ZIAGEN 111 32 10 23 506
TRAZODONE HCL 111 0 23 60
LISINOPRIL 107 58 25 3
OXYCODONE HCL 103 24 S2 26 162
MIRTAZAPINE 102 15 27 70
ANDROGEL 92 14 S3 28 279
BUPROPION HCL SR 91 16 29 296
LAMIVUDINE 86 12 30 443
FLUOXETINE HCL 84 15 31 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 0 32 134
NORTRIPTYLINE HCL 77 14 33 171
LEXIVA 73 12 34 511
PROAIR HFA 72 19 35 32
METOPROLOL SUCCINATE 72 20 35 24
SUMATRIPTAN SUCCINATE 67 0 37 306
QUETIAPINE FUMARATE 66 29 38 101
DIPHENOXYLATE-ATROPINE 66 0 38 214
ENALAPRIL MALEATE 64 0 40 75
TRAMADOL HCL 61 0 41 30
PRAVASTATIN SODIUM 61 0 41 20
ATENOLOL 60 22 43 8
LOSARTAN POTASSIUM 60 26 43 12
PREDNISONE 58 32 45 57
INDAPAMIDE 57 20 46 378
HYDROCHLOROTHIAZIDE 55 24 47 9
VIRAMUNE 55 14 47 544
EDURANT 54 0 10 49 728
NEXIUM 54 11 49 40
LYRICA 53 0 51 127
NABUMETONE 52 19 52 190
LEVOTHYROXINE SODIUM 51 23 53 4
SPIRIVA 50 20 54 65
ABACAVIR 50 16 54 750
IBUPROFEN 50 0 54 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.